VRX Share Price

Open 15.75 Change Price %
High 15.89 1 Day 0.02 0.13
Low 15.35 1 Week 0.01 0.06
Close 15.46 1 Month -1.36 -8.09
Volume 9218244 1 Year -81.73 -84.09
52 Week High 119.87
52 Week Low 13.77
VRX Important Levels
Resistance 2 15.96
Resistance 1 15.75
Pivot 15.57
Support 1 15.17
Support 2 14.96
NYSE USA Most Active Stocks
BAC 23.09 0.61%
BAC 23.09 0.61%
BAC 23.09 0.61%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
AMD 10.34 0.00%
More..
NYSE USA Top Gainers Stocks
INVN 10.55 27.57%
POM 26.93 26.79%
POM 26.93 26.79%
EBS 32.37 18.92%
EBS 32.37 18.92%
SWC 17.32 17.98%
SWC 17.32 17.98%
PACD 5.33 17.40%
SDLP 4.48 16.06%
UTI 3.55 14.15%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Valeant Pharmaceuticals International, Inc. (NYSE: VRX)

VRX Technical Analysis 5
As on 9th Dec 2016 VRX Share Price closed @ 15.46 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 36.52 & Strong Sell for SHORT-TERM with Stoploss of 20.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
VRX Target for December
1st Target up-side 21.53
2nd Target up-side 25.55
3rd Target up-side 29.57
1st Target down-side 10.05
2nd Target down-side 6.03
3rd Target down-side 2.01
VRX Other Details
Segment EQ
Market Capital 16095334400.00
Sector Healthcare
Industry Drug Delivery
Offical website http://www.valeant.com
VRX Address
VRX
2150 St. Elz
Laval, QC H7L 4A8
Canada
Phone: 514-744-6792
Fax: 514-744-6272
Interactive Technical Analysis Chart Valeant Pharmaceuticals International, Inc. ( VRX NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Valeant Pharmaceuticals International, Inc.
VRX Business Profile
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. Its pharmaceutical products include Solodyn, an oral antibiotic that treats red and pus-filled pimples, as well as Ziana, Acanya, and Atralin; Wellbutrin XL, a formulation used for the treatment of major depressive disorder in adults; Xenazine for the treatment of chorea; Zovirax Cream for herpes labialis; Zovirax ointment for initial genital herpes; The Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; and Prolensa, a non-steroidal anti-inflammatory ophthalmic solution. The company also provides OTC products, such as PreserVision, an antioxidant eye vitamin and mineral supplement; ReNu Multiplus, a sterile that is used to lubricate and rewet soft contact lenses; Ocuvite, a lutein eye vitamin and mineral supplement; Artelac, an eye drops to treat dry eyes; and CeraVe products for skin. In addition, it offers device products, including SofLens daily disposable contact lenses; Restylane, an injectable implant dermal fillers; PureVision, a contact lens; Dysport, an injection neurotoxin; ophthalmic surgical products, such as Akreos and Crystalens; surgical equipment comprising the VICTUS femtosecond laser and the Stellaris PC, a vitreoretinal and cataract surgery system; and medical device systems for aesthetic applications. Further, it provides generic products comprising Retin-A Micro, a tretinoin gel; tobramycin and dexamethasone ophthalmic suspensions for steroid responsive inflammatory ocular conditions; and latanoprost to treat glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.